Zhongtai Securities Co., Ltd.
Regarding
Tuoxin Pharmaceutical Group Co., Ltd.
2026 Annual Issuance of Shares to Specific Targets
Issuance Sponsorship Letter
(Application Draft)
Sponsor (Lead Underwriter)
(Building 3, Zone 5, Hanyu Financial Business Center, No. 7000 Jingshi Road, High-tech Zone, Jinan City)
July 2026
Sponsor and Sponsorship Representative Statement
Zhongtai Securities Co., Ltd. (hereinafter referred to as "Zhongtai Securities," "Sponsor," or "this Sponsor") has been engaged by Tuoxin Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company," "the Issuer," or "Tuoxin Pharmaceutical") to act as the sponsor for its 2026 annual issuance of shares to specific targets. We have designated Li Zhibin and Xu Baiqing as the sponsorship representatives for this project and hereby issue this Issuance Sponsorship Letter to the Shenzhen Stock Exchange (hereinafter referred to as "SZSE").
Zhongtai Securities and its sponsorship representatives, in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Administrative Measures for the Registration of Securities Issuance by Listed Companies, the Standards for the Contents and Formats of Information Disclosure by Companies Offering Securities No. 27—Issuance Sponsorship Letter and Issuance Sponsorship Work Report, the Administrative Measures for the Sponsorship of Securities Issuance and Listing, and other relevant laws, regulations, and provisions of the China Securities Regulatory Commission (CSRC) and the SZSE, have acted with honesty, trustworthiness, and due diligence. We have strictly followed the legally formulated business rules, industry practice standards, and ethical codes to issue this Issuance Sponsorship Letter, and we guarantee the authenticity, accuracy, and completeness of the documents provided. If the documents prepared and issued by the Sponsor for this issuance contain false records, misleading statements, or major omissions, causing losses to investors, the Sponsor will compensate investors for their losses in accordance with the law.
Table of Contents
-
Sponsor and Sponsorship Representative Statement
-
Table of Contents
-
Definitions
-
Section I: Basic Information on This Securities Issuance
-
I. Introduction to the Sponsor, Sponsorship Representatives, and Project Team Members
-
II. Type of Securities Issuance by the Issuer
-
III. Introduction to the Issuer's Basic Information
-
IV. Statement on Matters That May Affect the Fair Performance of Duties by the Sponsor
-
V. Sponsor's Internal Review Procedures and Kernel Opinions
-
Section II: Sponsor's Commitments
-
Section III: Sponsor's Recommendation Opinion on This Securities Issuance
-
I. Decision-making Procedures Performed by the Issuer Regarding This Securities Issuance
-
II. Statement on the Compliance of This Securities Issuance
-
III. Major Risks Facing the Issuer
-
IV. Evaluation of the Issuer's Development Prospects
-
V. Verification Opinion on the Issuer's Implementation of the "Guiding Opinions on Matters Concerning the Dilution of Immediate Returns in Initial Public Offerings, Refinancing, and Major Asset Restructurings"
-
VI. Verification of Paid Engagement of Third-Party Institutions and Individuals
-
VII. Sponsor's Recommendation Opinion
- Special Authorization Letter for Sponsorship Representatives of Zhongtai Securities Co., Ltd.
Definitions
Unless otherwise specified in the context, the terms in this Issuance Sponsorship Letter have the following meanings: